ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,131, issued on Oct. 14, was assigned to UXN Co. Ltd. (Suwon-si, South Korea).
"Glucose sensor apparatus addressing interference of ascorbic acid and acetaminophen" was invented by Sejin Park (Suwon-si, South Korea), Rae Kyu Chang (Seongnam-si, South Korea) and Hankil Boo (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to an apparatus for glucose-sensing that address interference of ascorbic acid and acetaminophen. The apparatus includes a first electrode capable of oxidizing glucose and at least one of ascorbic acid and acetaminophen. The apparatus further includes a second electrode capable of oxidizing at...